Top 5 U.S. stock research websites for 2022:

Although Yahoo Finance is renowned for its extensive free offerings, it does offer a paid subscription service. Yahoo Finance Plus comes in two tiers: Yahoo Finance Premium and Yahoo Finance Lite. The Premium plan costs $29.16 per month and provides research reports from Morningstar and Argus, market summaries, daily trading insights, fair-value analysis tools, portfolio tracking, and community features. The Lite plan costs $20.83 per month and delivers a similarly broad suite of services. (Figure 4) That said, personally, I find Yahoo Finance’s free tier the most cost-effective — truly the best way to ‘grab value for free’! 4. TradingView — A Must-Have Tool for Technical Traders TradingView is a technical-analysis–focused investment research platform widely used by professional traders for day-to-day operations. It delivers real-time stock charts covering numerous exchanges, complete with key technical indicators such as RSI, moving averages, and Bollinger Bands. Additionally, it offers customizable technical analysis tools—including critical metrics, historical annual financial data, volume indicators, MACD, and backtesting capabilities. If you’re a technical investor, TradingView is your top choice. Its free tier includes a highly functional heatmap, ideal for quickly identifying trending stocks. (Figure 5) TradingView’s UI design resonates strongly with me — clean, modern, and youth-oriented. Moreover, its coverage of global market information is comprehensive, giving it a distinct edge if you monitor international equities. Like other platforms, TradingView offers both free and paid plans. Its paid subscriptions range from $14.95 to $59.95 per month. Subscribers gain access to real-time market data, chart creation, portfolio tracking, and the ability to share technical charts and investment insights within trading communities. You can also set price alerts to stay promptly informed about significant stock movements. 5. Zacks — A Trusted Veteran Platform Zacks Investment Research (commonly known as Zacks) is a comprehensive stock analysis website. Its free services include market data, stock market information, and related financial and market news. Also included are average target prices, analyst recommendations, earnings, and dividend data for individual stocks. Its premium offerings emphasize fundamental-analysis–driven tools. For example, Zacks places strong emphasis on earnings forecasts, believing that stocks exhibiting consistently rising earnings estimates have greater potential to outperform the market. It also provides technical analysis tools — including TradingView-style charts. Zacks’ paid services further include the Zacks #1 Rank List, long-term stock portfolios, an advanced stock screener, and in-depth stock research reports. The stock screener enables investors to filter stocks based on personalized investment criteria — including price changes, dividends, EPS estimates, and Zacks Rank, among other fundamental metrics.

U.S. stock earnings report — Vertiv Q1 FY2026 (reported on 2026-04-22)

Thesis Impact: Neutral-to-positive. Backlog: $15B (+109% YoY); Book-to-bill ratio: 2.9x — implying ~1.53x annualized revenue visibility, significantly exceeding Eaton’s or Schneider’s. AI data center capex cycle remains intact. Earnings Details: Vertiv Holdings (VRT) — Q1 FY2026 Earnings Update Report Date: April 22, 2026 (earnings day) | Release Time: Pre-market (NYSE) | Fiscal Quarter Ended: March 31, 2026 Key Takeaway: Results beat expectations + guidance raised; positive catalysts already largely priced into the stock at its all-time high. Vertiv’s Q1 FY2026 results exceeded expectations across the board: Revenue of $2.65B (+30% YoY, +23% organic), adjusted EPS of $1.17 vs. consensus of $1.02 (+15%), adjusted operating margin of 20.8% (+430 bps YoY), and adjusted FCF of $653M (+147% YoY). Management raised FY2026 adjusted EPS guidance from $6.00–$6.20 to $6.30–$6.40 (midpoint +3.1%) and sales guidance from $13.0–13.4B to $13.5–14.0B. Today’s stock price declined only -2.4% (prior close $312.44 → current $305.09; pre-market low was -5.5%, later rebounding), reflecting modest profit-taking after YTD +88% / January +19% gains—not disappointment over guidance. Market concerns: FY2026 sales guidance midpoint of $13.75B barely matches consensus of $13.7B (especially given Q4 orders surged +252%, raising expectations further), and EMEA organic revenue fell -29%, fueling concerns about regional imbalance. Fundamentals remain solid: backlog stands at $15B (+109% YoY); book-to-bill ratio ~2.9x; AI data center demand unchanged. The stock now trades at 48x FY2026E / 38x FY2027E — elevated valuation, yet PEG of 1.3x remains reasonable. Maintain Buy rating; target price $335, based on FY2027E adjusted EPS of $8.38 at 40x multiple — premium versus Eaton’s 23x reflects VRT’s 30% growth rate vs. ETN’s 11%. Q1 FY2026 Key Metrics Metric Q1 FY2026 Actual Consensus Beat/Miss YoY Revenue $2.65B $2.64B +0.4% +30% Organic Revenue Growth +23% +22% +100 bps — Adjusted EPS $1.17 $1.02 +$0.15 (+15%) +83%

Zacks Upgrades Stepan Company Stock to Strong Buy

Oct 6, 2026

Zacks Research upgraded Stepan Company stock to Strong Buy after Q2 2026 earnings beat consensus, reporting adjusted EPS of USD 1.18 and revenue of USD 684.11 million.

AD HOC NEWS

2026-02-23

US Stepan to close New Jersey surfactants site; decommission other assets by mid-2026

2026-02-24

Stepan to shutter assets under $100M savings plan

2026-03-03

Stepan Company Launches Cost-Cutting Plan

2026-04-02

Stepan Stock Crosses 200-Day Moving Average Despite Earnings Miss

2026-04-03

Stepan Company Stock: Steady in Volatile Materials Sector—What You Need to Watch